617
Views
6
CrossRef citations to date
0
Altmetric
Articles

Effect of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 796-809 | Received 30 Apr 2021, Accepted 28 Jul 2021, Published online: 20 Aug 2021

References

  • Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. 2015. World Alzheimer Report 2015 – The global impact of dementia: An analysis of prevalence, incidence, cost and trends. London: Alzheimer’s Disease International.
  • Asada T. 2013. Health and Labour Sciences Research Grants, Comprehensive Research Project on Dementia Measures – Comprehensive research report, FY2011-12. Ministry of Health, Labour and Welfare, Japan. (Japanese):1–26. http://www.tsukuba-psychiatry.com/wp-content/uploads/2013/06/H24Report_Part1.pdf.
  • Ninomiya T. 2015. Health and Labour Sciences Research Grants, Health and labour Sciences Special Research Project – Comprehensive research report, FY2014. Ministry of Health, Labour and Welfare, Japan. (Japanese):20–24. https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201405037A.
  • OECD. 2017. Health at a Glance 2017: OECD Indicators. OECD Publishing, Paris.
  • Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr. 2004; 16(2):129–40. doi:10.1017/s1041610204000092.
  • Maebuchi M, Suzuki M, Tsumura K, Miura N, Okuda J. Dose response study of effect of soy peptide intake on cognitive function in healthy middle-aged and elderly participants – A randomized, double-blind, placebo-controlled study. Jpn Pharmacol Ther. 2017; 45(9):1535–45.
  • Maebuchi M, Suzuki M, Miura N, Okuda J. Dose response study examining the effects of soy peptide supplementation on cognitive function in healthy subjects – A randomized, double-blind, placebo-controlled study. Jpn Pharmacol Ther. 2016; 44(12):1831–9.
  • Raghav S, Singh H, Dalal PK, Srivastava JS, Asthana OP. Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment. Indian J Psychiatry. 2006; 48(4):238–42. doi:10.4103/0019-5545.31555.
  • Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology. 2002; 27(2):279–81. doi:10.1016/S0893-133X(01)00419-5.
  • Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N, Jr., Stedman M, MIDAS Investigators. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010;6(6):456–64. doi:10.1016/j.jalz.2010.01.013.
  • Takimoto Y, Tabata R, Ito A, Kondo S. Effects of Ginkgo biloba extract-containing dietary supplement on cognitive function in healthy, cognitively intact middle-aged to older adults -randomized, double-blind, placebo-controlled parallel-group trial. Jpn Pharmacol Ther. 2017; 45(6):975–87.
  • Yamatsu A, Nakamura U, Saddam HM, Horie N, Kaneko T, Kim M. Intake of 200 mg/day of γ-aminobutyric acid (GABA) improves a wide range of cognitive functions – A randomized, double-blind, placebo-controlled parallel-group clinical trial. Jpn Pharmacol Ther. 2020; 48(3):461–74.
  • Yamatsu A, Nakamura U, Saddam HM, Horie N, Kaneko T, Kim M. Improvement of memory and spatial cognitive function by continuous ingestion of 100 mg/day of γ-aminobutyric acid (GABA) – A randomized, double-blind, placebo-controlled parallel-group clinical trial. Jpn Pharmacol Ther. 2020; 48(3):475–86.
  • Kawamura J, Kotoura S, Ando T, Kawasaki Y, Ebihara S. The evaluation test of brain function by oral consumption of the food which contain plasmalogen – Randomized, placebo-controlled, double-blind parallel-group study. Jpn Pharmacol Ther. 2019; 47(5):739–49.
  • Watanabe H, Okawara M, Matahira Y, Mano T, Wada T, Suzuki N, Takara T. Secondary analysis of a randomized, double-blind, placebo-controlled trial to evaluate the impact of ascidian (Halocynthia roretzi)-derived plasmalogen on cognitive function in healthy humans. Pharmacometrics. 2019; 96(1/2):11–9.
  • Kato-Kataoka A, Sakai M, Ebina R, Nonaka C, Asano T, Miyamori T. Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. J Clin Biochem Nutr. 2010; 47(3):246–55. doi:10.3164/jcbn.10-62.
  • Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, Martinez J, Wong K-P, Liu J, Merrill DA, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: A double-blind, placebo-controlled 18-month trial. Am J Geriatr Psychiatry. 2018; 26(3):266–77. doi:10.1016/j.jagp.2017.10.010.
  • Sekikawa T, Kizawa Y, Li Y, Takara T. Cognitive function improvement with astaxanthin intake: A randomized, double-blind, placebo-controlled study. Pharmacometrics. 2019;97(1/2):1–13.
  • Itoh Y, Hine K, Miura H, Uetake T, Nakano M, Takemura N, Sakatani K. Effect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQTM) on cognitive functions. Adv Exp Med Biol. 2016;876:319–25.
  • Kumazawa T, Sato K, Seno H, Ishii A, Suzuki O. Levels of pyrroloquinoline quinone in various foods. Biochem J. 1995;307(Pt 2):331–3. doi:10.1042/bj3070331.
  • Kumazawa T, Seno H, Suzuki O. Failure to verify high levels of pyrroloquinoline quinone in eggs and skim milk. Biochem Biophys Res Commun. 1993; 193(1):1–5. doi:10.1006/bbrc.1993.1581.
  • Mitchell AE, Jones AD, Mercer RS, Rucker RB. Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk. Anal Biochem. 1999;269(2):317–25. doi:10.1006/abio.1999.4039.
  • Kumazawa T, Seno H, Urakami T, Matsumoto T, Suzuki O. Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry. Biochim Biophys Acta. 1992; 1156(1):62–6. doi:10.1016/0304-4165(92)90096-D.
  • Harris CB, Chowanadisai W, Mishchuk DO, Satre MA, Slupsky CM, Rucker RB. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem. 2013; 24(12):2076–84. doi:10.1016/j.jnutbio.2013.07.008.
  • Smidt CR, Unkefer CJ, Houck DR, Rucker RB. Intestinal absorption and tissue distribution of [14C]pyrroloquinoline quinone in mice. Proc Soc Exp Biol Med. 1991; 197(1):27–31. doi:10.3181/00379727-197-43219.
  • Rucker R, Chowanadisai W, Nakano M. Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev. 2009; 14(3):268–77.
  • Akagawa M, Nakano M, Ikemoto K. Recent progress in studies on the health benefits of pyrroloquinoline quinone. Biosci Biotechnol Biochem. 2016; 80(1):13–22. doi:10.1080/09168451.2015.1062715.
  • Steinberg FM, Gershwin ME, Rucker RB. Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J Nutr. 1994; 124(5):744–53. doi:10.1093/jn/124.5.744.
  • Stites T, Storms D, Bauerly K, Mah J, Harris C, Fascetti A, Rogers Q, Tchaparian E, Satre M, Rucker RB. Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr. 2006; 136(2):390–6. doi:10.1093/jn/136.2.390.
  • Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, Rucker RB. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J Biol Chem. 2010; 285(1):142–52. doi:10.1074/jbc.M109.030130.
  • Uchino H, Honma T, Hatakeyama K. Brain damage and mitochondrial dysfunction. Anesth 21 Century. 2011; 13(1-39):61–7.
  • Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol. 2006; 21(7):623–43. doi:10.1016/j.acn.2006.05.007.
  • Ritchie K, Fuhrer R. The validation of an informant screening test for irreversible cognitive decline in the elderly: performance characteristics within a general population sample. Int J Geriat Psychiatry. 1996; 11(2):149–56. doi:10.1002/(SICI)1099-1166(199602)11:2<149::AID-GPS298>3.0.CO;2-5.
  • Sugishita M, Koshizuka Y, Sudou S, Sugishita K, Hemmi I, Karasawa H, Ihara M, Asada T, Mihara B. The validity and reliability of the Japanese version of the mini-mental state examination (MMSE-J) with the original procedure of the attention and calculation task. Jpn J Cogn Neurosci. 2001;20(2):91–110.
  • Silverman DHS. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med. 2004; 45(4):594–607.
  • Gualtieri CT, Johnson LG. Neurocognitive testing supports a broader concept of mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2005; 20(6):359–66. doi:10.1177/153331750502000607.
  • Sandrini M, Brambilla M, Manenti R, Rosini S, Cohen LG, Cotelli M. Noninvasive stimulation of prefrontal cortex strengthens existing episodic memories and reduces forgetting in the elderly. Front Aging Neurosci. 2014;6(289).
  • Akagawa M, Minematsu K, Shibata T, Kondo T, Ishii T, Uchida K. Identification of lactate dehydrogenase as a mammalian pyrroloquinoline quinone (PQQ)-binding protein. Sci Rep. 2016; 6:26723. doi:10.1038/srep26723.
  • Saihara K, Kamikubo R, Ikemoto K, Uchida K, Akagawa M. Pyrroloquinoline quinone, a redox-active o-quinone, stimulates mitochondrial biogenesis by activating the SIRT1/PGC-1α signaling pathway. Biochemistry. 2017; 56(50):6615–25. doi:10.1021/acs.biochem.7b01185.
  • Horio Y, Hayashi T, Kuno A, Kunimoto R. Cellular and molecular effects of sirtuins in health and disease. Clin Sci (Lond). 2011; 121(5):191–203. doi:10.1042/CS20100587.
  • Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. Embo J. 2007; 26(13):3169–79. doi:10.1038/sj.emboj.7601758.
  • Kumar A, Bagchi D. (Editors) Antioxidants and functional foods for neurodegenerative disorders: Uses in prevention and therapy. 2021. Boca Raton (FL): CRC Press/Taylor & Francis.
  • Subhan S, Bagchi M. (Editors) Phytopharmaceuticals in brain health. 2017. Boca Raton (FL): CRC Press/Taylor & Francis.
  • Rucker R, Stites T, Suzuki Y, Steinberg F, Storms D. Physiological importance of pyrroloquinoline quinone. Vitamin (Japan). 2001; 75(7):381–7.
  • Paz MA, Martin P, Fluckiger R, Mah J, Gallop PM. The catalysis of redox cycling by pyrroloquinoline quinone (PQQ), PQQ derivatives, and isomers and the specificity of inhibitors. Anal Biochem. 1996; 238(2):145–9. doi:10.1006/abio.1996.0267.
  • Paz MA, Fluckiger R, Gallop PM. Comment: Redox-cycling is a property of PQQ but not of ascorbate. FEBS Lett. 1990; 264(2):283–4. doi:10.1016/0014-5793(90)80268-n.
  • Ouchi A, Nakano M, Nagaoka S, Mukai K. Kinetic study of the antioxidant activity of Pyrroloquinolinequinol (PQQH(2), a reduced form of pyrroloquinolinequinone) in micellar solution. J Agric Food Chem. 2009; 57(2):450–6. doi:10.1021/jf802197d.
  • Mukai K, Ouchi A, Nakano M. Kinetic study of the quenching reaction of singlet oxygen by Pyrroloquinolinequinol (PQQH(2), a reduced form of Pyrroloquinolinequinone) in micellar solution. J Agric Food Chem. 2011; 59(5):1705–12. doi:10.1021/jf104420y.
  • Jensen FE, Gardner GJ, Williams AP, Gallop PM, Aizenman E, Rosenberg PA. The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neurosci. 1994; 62(2):399–406. doi:10.1016/0306-4522(94)90375-1.
  • Zhang Y, Feustel PJ, Kimelberg HK. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res. 2006; 1094(1):200–6. doi:10.1016/j.brainres.2006.03.111.
  • Ohwada K, Takeda H, Yamazaki M, Isogai H, Nakano M, Shimomura M, Fukui K, Urano S. Pyrroloquinoline quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats. J Clin Biochem Nutr. 2008; 42(1):29–34. doi:10.3164/jcbn.2008005.
  • Nunome K, Miyazaki S, Nakano M, Iguchi-Ariga S, Ariga H. Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol Pharm Bull. 2008; 31(7):1321–6. doi:10.1248/bpb.31.1321.
  • Hara H, Hiramatsu H, Adachi T. Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem Res. 2007; 32(3):489–95. doi:10.1007/s11064-006-9257-x.
  • Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci. 2001; 24:677–736. doi:10.1146/annurev.neuro.24.1.677.
  • Yamaguchi K, Sasano A, Urakami T, Tsuji T, Kondo K. Stimulation of nerve growth factor production by pyrroloquinoline quinone and its derivatives in vitro and in vivo. Biosci Biotechnol Biochem. 1993; 57 (7):1231–3. doi:10.1271/bbb.57.1231.
  • Lee S-R, Kwon K-S, Kim S-R, Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem. 1998; 273(25):15366–72. doi:10.1074/jbc.273.25.15366.
  • Iwamoto N, Sumi D, Ishii T, Uchida K, Cho AK, Froines JR, Kumagai Y. Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor. J Biol Chem. 2007; 282(46):33396–404. doi:10.1074/jbc.M705224200.
  • Shibata T, Nakahara H, Kita N, Matsubara Y, Han C, Morimitsu Y, Iwamoto N, Kumagai Y, Nishida M, Kurose H, et al. A food-derived synergist of NGF signaling: identification of protein tyrosine phosphatase 1B as a key regulator of NGF receptor-initiated signal transduction. J Neurochem. 2008; 107(5):1248–60. doi:10.1111/j.1471-4159.2008.05686.x.
  • Kimura K, Takada M, Ishii T, Tsuji-Naito K, Akagawa M. Pyrroloquinoline quinone stimulates epithelial cell proliferation by activating epidermal growth factor receptor through redox cycling. Free Radic Biol Med. 2012; 53(6):1239–51. doi:10.1016/j.freeradbiomed.2012.07.015.
  • Yamazaki M. 4. Neuroimaging and clinical pictures of neurological disorders, neuropathology of degenerative dementia (IV). J Nippon Med Sch. 2008; 4(3):140–2.
  • Kim J, Kobayashi M, Fukuda M, Ogasawara D, Kobayashi N, Han S, Nakamura C, Inada M, Miyaura C, Ikebukuro K, et al. Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins. Prion. 2010; 4(1):26–31. doi:10.4161/pri.4.1.10889.
  • Kobayashi M, Kim J, Kobayashi N, Han S, Nakamura C, Ikebukuro K, Sode K. Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein. Biochem Biophys Res Commun. 2006; 349(3):1139–44. doi:10.1016/j.bbrc.2006.08.144.
  • Takatsu H, Owada K, Abe K, Nakano M, Urano S. Effect of vitamin E on learning and memory deficit in aged rats. J Nutr Sci Vitaminol (Tokyo). 2009;55(5):389–93. doi:10.3177/jnsv.55.389.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.